Serina Therapeutics (SER) Asset Utilization Ratio (2019 - 2026)
Serina Therapeutics (SER) posted Asset Utilization Ratio of 0.01 for Q4 2025, up 23.59% sequentially from 0.01 in Q3 2025, and up 69.74% YoY from 0.01 in Q4 2024.
Serina Therapeutics (SER) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Serina Therapeutics has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.01 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 69.74% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (up 69.74% YoY) and the FY2025 annual result came in at 0.02, up 166.38% from the prior year.
- Asset Utilization Ratio rose to 0.01 in Q4 2025 per SER's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.35 in Q3 2024 and troughed at 0.01 in Q1 2025.
- A 5-year average of 0.11 and a median of 0.08 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio soared 2887.97% in 2024, then tumbled 97.6% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.1 in 2021, then plunged by 86.95% to 0.01 in 2022, then jumped by 2198.46% to 0.3 in 2023, then slumped by 97.34% to 0.01 in 2024, then jumped by 69.74% to 0.01 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 0.13 |
| 10 | Serina Therapeutics | 44.65 Mn | 21.63 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.11 |